Έμβλημα Κυπριακής Δημοκρατίας

News


Notification of a concentration regarding the acquisition of the share capital of Wild River Corporation S.a.r.l. by European Medco Development 4 S.a.r.l.
23/03/2020


The Office of the Competition Protection Committee announces that Bridgepoint Group Ltd, has notified that it intends to acquire the share capital of Wild River Corporation S.a.r.l. via European Medco Development 4 S.a.r.l.

Wild River Corporation S.a.r.l. is a limited liability company duly registered in accordance with Luxembourg laws. This company is the parent of PharmaZell group of companies, manufacturer of specialized active pharmaceutical components and natural substances.

European Medco Development 4 S.a.r.l.is a special purpose vehicle, established for the purposes of the proposed transaction. This company is controlled by the Bridgepoint Europe VI Fund, a European fund consisting of a series of limited partnerships, on behalf of which Bridgepoint Advisors Limited, an English limited liability company, which acts as an Administrator. Bridgepoint Group Limited, an English limited liability company, is the ultimate parent company of Bridgepoint Advisors Limited. Bridgepoint holding companies operate in various industries and business sectors including Business Services, Financial Services, Media Information & Technology, Consumer, Healthcare and Manufacturing & Industry.








Cartel Hotline

Commission Decisions

e-procurement

About Cyprus

Your Europe